Abstract. pyrimidin-4-yl)morpholine derivatives is an important intermediate which inhibited tumor necrosis factor alpha and nitric oxide. In this work, a rapid and green synthetic method for compound (5) was established. The compound (5) was synthesized from the commercially available methyl 3-aminothiophene-2-carboxylate and formamidine acetate through three steps including condensation reaction, chlorination, and nucleophilic substitution. The structure was confirmed by 1 H NMR and MS. Furthermore, the total yield of the three steps was 43%.
Introduction
Thienopyrimidine is a key intermediate which has many applications in research work. Many articles have reported that a series of substituted thienopyrimidine derivatives were synthesized [1] [2] . Most of the thienopyrimidine derivatives inhibited tumor necrosis factor alpha and nitric oxide, it was also confirmed to be a potent inhibitor for acute myeloid leukemia. In addition, the research team occasionally find that the thienopyrimidine analogues didn't IKKb inhibitory activities, nevertheless it's has a effective on acute myeloid leukemia [3] . At the same times, many articles have repoted that thienopyrimidine derivatives have a antimicrobial activity [4] [5] [6] . One of the literature points out some 2-substituted thienopirimidin-4-one derivatives may serve as novel spasmolytic agents to treat disorders of smooth muscle function. In addition to, thieno [3,2-d] pyrimidine derivatives inhibit PI3 kinase p110α. Phosphatidylinositol-3-kinase (PI3K) is an important cancer target which deregulates the PI3K/Akt signaling pathway in a wide variety of tumors [7] . The representative of the PI3K inhibitor is GDC-0941, and it's structure in Fig 1. The latest literature shows that thieno [3,4-d] -pyrimidine as a common heterocyclic nucleus, the research team reinstall this functionality into a new isomorphic RNA alphabet, with higher structural and electronic similarity to the native purines, therefore it can be better simulate the role of purine [8] . While the thieno[3,4-d]-pyrimidine has a highly emissive and valuable as illustrated by several applications [9] and its structure was shown in Fig 1. At the same times, some literatures have reported that the thienopyrimidine core can be used in preparing potent P2Y12 inhibitors [10] . Most of the synthetic methods of thieno[3,2-d]-pyrimidine which was reported in the literature have the drawbacks such as low yield, harmful to environment and long synthetic route. Based on our previous research, through three steps we have synthesized the title compound of thienopyrimidine, including condensation reaction, chlorination, and nucleophilic substitution, and those methods easy, non-toxic, and green.
In this study, we designed and optimized the synthetic methods for 4-(thieno[3,2-d]pyrimidin-4-yl)morpholine (5) and made it more suitable for industrial production. The target compound structure was shown in 
Materials and Methods
All chemicals and reagents used in current study were of analytical grade. NMR spectra were performed using Bruker 300 MHz spectrometers (Bruker Bioscience, Billerica, MA, USA) with TMS as an internal standard. Mass spectra (MS) were taken in ESI mode on Agilent 1100 LC-MS (Agilent, Palo Alto, CA, USA). Elemental analysis was determined on a Carlo-Erba 1106 Elemental analysis instrument (Carlo Erba, Milan, Italy). All the materials were obtained from commercial suppliers and used without purification, unless otherwise specified. Yields were not optimized. TLC analysis was carried out on silica gel plates GF254 (Qindao Haiyang Chemical, China).
Synthesis of Compounds
The structures and the synthetic route were shown in Scheme 1. 3 g, 19.8 mmol) was suspended in DMF (15 mL) , then phosphoryl trichloride(35 mL) was added and the mixture stirred at the 80 ℃ for 3 h. The reaction precedure was monitored by the TLC, after the reaction completed, it was slowly poured it into ice-cold water, and the mixture was stirred at room temperature. The solid product formed was filtered, washed with water, dried and crystallized from ethanol. Yield 85%, mp: 115-118 ℃. 1 mmol) and morpholine(0.85 mL) were dissolved in ethanol(15 mL) and refluxed to give the desired compound (5) . After the reaction completed, the product was extracted with dichloromethane(DCM) and water, the extract was washed successively with water, dried over anhydrous Na 2 SO 4 , filtered and evaporated, then to give 4-(thieno [3,2- 
Conclusions
In conclusion, the target compound 4-(thieno[3,2-d]pyrimidin-4-yl)morpholine (5) was synthesized starting from the simple derivatives of methyl 3-aminothiophene-2-carboxylate (1) and formamidine acetate (2) through three steps including nucleophilic substitution, chlorination. The synthetic method of compound (5) and the reactions conditions were optimized, the purity of the product is high. All the compounds structure was confirmed by 1H NMR spectrum and MS.
